A simple clinical risk score based on age, sex and BMI predicts long-term survival in NAFLD: analysis from a large public dataset

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background Non-alcoholic fatty liver disease (NAFLD) represents a growing global health challenge, yet no widely accepted clinical tool exists to stratify patients by mortality risk using basic demographic and anthropometric parameters. Aim To develop and validate a simple clinical score based on age, sex and BMI to predict long-term survival in NAFLD patients. Methods We conducted a retrospective survival analysis on 17,549 patients with NAFLD, using data derived from the Nonalcoholic Fatty Liver Disease Adult Database 2 (NAFLD Adult Database 2), managed by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). A three-point clinical risk score was developed by assigning one point each for age >60 years, male sex, and BMI >30 kg/m² (range 0–3). The primary outcome was overall survival, defined by the variable status over follow-up time (futime). Kaplan-Meier survival estimates and Cox proportional hazards models were used to assess the prognostic utility of the score. Results Among included patients, 46.7% were male and 7.8% experienced the primary outcome. The distribution of risk scores was: 0 (1.4%), 1 (25.5%), 2 (50.4%), and 3 (22.8%). Median survival increased from 2111 months in the score 0 group to 2327 months in the score 2 group. Patients with score 3 had a modest but statistically significant increase in risk compared to score 0 (HR = 1.09; 95% CI: 1.00–1.17; p = 0.044), while score 2 was associated with lower risk (HR = 0.87; 95% CI: 0.79–0.97; p = 0.010). Kaplan-Meier curves showed clear separation of survival probabilities across score categories. The 5-year survival was 100% (score 0), 99.7% (score 1–2), and 99.4% (score 3). Conclusion A clinical score based on age, sex and BMI provides a simple yet effective tool for mortality risk stratification in NAFLD. This model may help guide follow-up strategies and early interventions in clinical settings.

Article activity feed